Pomerantz LLP, a leading law firm specializing in corporate, securities, and antitrust class litigation, has initiated an investigation into Abeona Therapeutics Inc. (NASDAQ: ABEO) on…
Biotechnology
Investors Alerted of Class Action Lawsuit against Altimmune, Inc.
A class-action lawsuit has been filed against Altimmune, Inc. (NASDAQ: ALT) by the Rosen Law Firm, a well-respected global investor rights law firm. The lawsuit…
Rosen Law Firm Provides Important Deadline Reminder in Exscientia Securities Class Action – June 25, 2024
Rosen Law Firm, a well-known investor rights law firm, is reminding individuals who purchased securities of Exscientia p.l.c (NASDAQ: EXAI) between the dates of March…
Breakthroughs in RNA Technology Promote Expansion of Vaccine and Therapeutic Applications
SAN DIEGO, May 11, 2024 /PRNewswire/ — Replicate Bioscience, a pioneer in self-replicating RNA (srRNA) technology, presented groundbreaking findings at the American Society of Gene…
Ventyx Biosciences Faces Investigation for Potential Breach of Fiduciary Duties
Ventyx Biosciences, a prominent biotechnology company, is currently under investigation by Bleichmar Fonti & Auld LLP (BFA) over potential breaches of fiduciary duties. Shareholders are…
Caliway Biopharmaceuticals to Showcase Groundbreaking Clinical Advancements at the 2024 BIO International Convention
Taiwan-based Caliway Biopharmaceuticals is gearing up to share the latest developments in the field of medical aesthetics and inflammatory disease at the highly-anticipated 2024 BIO…
Investors Alerted to Securities Class Action Lawsuit Against Akero Therapeutics
Investors who purchased shares of Akero Therapeutics, Inc. (NasdaqGS: AKRO) between September 13, 2022, and October 9, 2023, have been reminded by Kahn Swick &…
WestGene Introduces Groundbreaking mRNA Therapeutic Cancer Vaccine
WestGene, a biotechnology company specializing in mRNA technology, has achieved a historic milestone with the approval of its mRNA therapeutic cancer vaccine, WGc-043, by the…
Leading Law Firm Investigates Potential Claims Against Checkpoint Therapeutics
A renowned national securities law firm, Faruqi & Faruqi, LLP, is currently conducting an investigation into potential claims against Checkpoint Therapeutics, Inc. (NASDAQ: CKPT). The…
Intensity Therapeutics Partners with SAKK to Advance Novel Cancer Therapy
Intensity Therapeutics, a leading clinical biotechnology company, has announced a groundbreaking collaboration with The Swiss Group for Clinical Cancer Research SAKK. Together, they will conduct…